The gut microbiota‐derived metabolite indole‐3‐propionic acid enhances leptin sensitivity by targeting STAT3 against diet‐induced obesity
Clinical and Translational Medicine · 2024-12 · 14 (12)
DOI: 10.1002/ctm2.70053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 28.11.2024. Verfasst von Zhiwei Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Wuxi School of Medicine, Jiangnan University, Wuxi, China. Hauptthemen laut MEDLINE: Obesity, Gastrointestinal Microbiome, Leptin, STAT3 Transcription Factor. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Obesity is associated with the gut microbiome. Here, we report that gut commensal Clostridia bacteria regulate host energy balance through the tryptophan‐derived metabolite indole‐3‐propionic acid (IPA). IPA acts as an endogenous leptin sensitiser to counteract obesity. Mechanistically, IPA is secreted from the gut into the circulation, and then targets to the STAT3 in the hypothalamic appetite regulation centre, promoting its phosphorylation and nuclear translocation, which enhances the body's response to leptin, and regulates the balance between appetite and energy metabolism. The in vitro pull‐down assays involving site‐directed mutagenesis demonstrate that Trp623 in the SH2 domain is the key binding site for STAT3‐IPA interaction. High‐fat diet (HFD), rather than genetic factors, induces excessive secretion of antimicrobial peptides by Paneth cells, inhibiting the growth of Clostridia in the gut and resulting in decreased production of the beneficial metabolite IPA. IPA or Clostridium sporogenes supplement effectively controls weight gain, improves glucose metabolism, and reduces inflammation in DIO mice. IPA fails to achieve such effects in ob/ob mice, while exogenous leptin administration restores the therapeutic effect of IPA. Our study suggests that the IPA‐based gut‐brain axis regulates host metabolism, and supplementation with microbiome‐derived IPA could be a promising intervention strategy for treating obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Wuxi School of Medicine, Jiangnan University, Wuxi, China.
- Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi, China.
ORCID-Profile: Zhiwei Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, Z., Yang, S., Liu, L., Mao, A., Kan, H., Yu, F., Ma, X., Feng, L., & Zhou, T. (2024). The gut microbiota‐derived metabolite indole‐3‐propionic acid enhances leptin sensitivity by targeting STAT3 against diet‐induced obesity. Clinical and Translational Medicine, 14(12). https://doi.org/10.1002/ctm2.70053
Vancouver
Wang Z, Yang S, Liu L, Mao A, Kan H, Yu F, et al. The gut microbiota‐derived metabolite indole‐3‐propionic acid enhances leptin sensitivity by targeting STAT3 against diet‐induced obesity. Clinical and Translational Medicine. 2024;14(12). doi:10.1002/ctm2.70053
BibTeX
@article{Wang2024,
author = {Wang, Zhiwei and Yang, Shaying and Liu, Liangju and Mao, Aiqin and Kan, Hao and Yu, Fan and Ma, Xin and Feng, Lei and Zhou, Tingting},
title = {The gut microbiota‐derived metabolite indole‐3‐propionic acid enhances leptin sensitivity by targeting STAT3 against diet‐induced obesity},
journal = {Clinical and Translational Medicine},
year = {2024},
volume = {14},
number = {12},
doi = {10.1002/ctm2.70053}
}
EUVIMED